Synthetic peroxides as antimalarizals

Medicinal Research Reviews

Volumn 24, Issue 4, 2004, Pages 425-448

  Tang, Yuanqing ^a   Dong, Yuxiang ^a   Vennerstrom, Jonathan L ^a,b  

^a UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^b UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

Author keywords

Antimalarials; Artemisinin; SAR; Synthetic peroxides

Indexed keywords

1,2,4 TRIOXANE DERIVATIVE; ANTIMALARIAL AGENT; ARTEFLENE; ARTEMETHER; ARTEMISININ; ARTEMISININ DERIVATIVE; ARTESUNATE; DIOXANE DERIVATIVE; ENDOPEROXIDE; HERBACEOUS AGENT; PEROXIDE; UNCLASSIFIED DRUG; YINGZHAOSU;

ANTIMALARIAL ACTIVITY; DRUG EFFICACY; DRUG HALF LIFE; DRUG POTENCY; DRUG SYNTHESIS; IN VITRO STUDY; IN VIVO STUDY; LIPOPHILICITY; NONHUMAN; PATIENT COMPLIANCE; PHYSICAL CHEMISTRY; REVIEW; STEREOCHEMISTRY; STRUCTURE ACTIVITY RELATION; SYSTEMATIC REVIEW; CHEMISTRY;

ANTIMALARIALS; PEROXIDES;

EID: 3042613588     PISSN: 01986325     EISSN: None     Source Type: Journal    
DOI: 10.1002/med.10066     Document Type: Review

References (130)

1. Sachs J, Malaney P. The economic and social burden of malaria. Nature 2002;415:680-685.
2. Ridley RG. Medical need, scientific opportunity, and the drive for antimalarial drugs. Nature 2002;415:686-693.
3. Klayman DL. Qinghaosu (artemisinin): An antimalarial drug from China. Science 1985;228:1049-1055.
4. White NJ. Antimalarial drug resistance and combination chemotherapy. Phil Trans R Soc Lond B 1999;354:739-749.
5. Hastings IM, Watkins WM, White NJ. The evolution of drug-resistant malaria: The role of drug elimination half-life. Phil Trans R Soc Lond B 2000;357:505-519.
6. Avery MA, Chong WKM, Jennings-White C. Stereoselective total synthesis of (+)-artemisisnin, the antimalarial constituent of Artemesia annua L. J Am Chem Soc 1992;114:974-979.
7. Schmid G, Hofheinz W. Total synthesis of qinghaosu. J Am Chem Soc 1983;105:624-625.
8. Xu XX, Zhu J, Huang DZ, Zhou WS. Total synthesis of arteannuin and deoxyarteannuin. Tetrahedron 1986;42:819-828.
9. Ravindranathan T, Ani-Kumar M, Menon RB, Hiremath SV. Stereoselective total synthesis of artemisisnin. Tetrahedron Lett 1990;31:755-758.
10. Jefford CW. Why artemisinin and certain synthetic peroxides are potent antimalarials. Implications for the mode of action. Curr Med Chem 2001;8:1803-1826.
11. Cumming JN, Ploypradith P, Posner GH. Antimalarial activity of artemisinin (qinghaosu) and related trioxanes: Mechanism(s) of action. Adv Pharm 1997;37:253-297.
12. Robert A, Dechy-Cabaret O, Cazelles J, Benoit-Vical F, Meunier B. Recent advances in malaria chemotherapy. J Chin Chem Soc 2002;49:301-310.
13. Meshnick SR. Artemisinin: Mechanisms of action, resistance, and toxicity. Int J Parasitol 2002;32:1655-1660.
14. Haynes RK, Vonwiller SC. The behavior of qinghaosu (artemisinin) in the presence of non-heme iron(II) and (III). Tetrahedron Lett 1996;37:257-260.
15. Haynes RK, Vonwiller SC. The behavior of qinghaosu (artemisinin) in the presence of heme iron(II) and (III). Tetrahedron Lett 1996;37:253-256.
16. Jefford CW. Peroxidic antimalarials. Adv Drug Res 1997;29:271-325.
17. Wu WM, Wu YK, Wu YL, Yao ZJ, Zhou CM, Li Y, Shan F. Unified mechanistic framework for the Fe(II)-induced cleavage of qinghaosu and derivatives/analogs. The first spin-trapping evidence for the previously postulated secondary C-4 radical. J Am Chem Soc 1998;120:3316-3325.
18. Meshnick SR, Jefford CW, Posner GH, Avery MA, Peters W. Second-generation antimalarial endoperoxides. Parasitol Today 1996;12:79-82.
19. Vroman JA, Alvim-Gaston M, Avery MA. Current progress in the chemistry, medicinal chemistry, and drug design of artemisinin based antimalarials. Curr Pharm Des 1999;5:101-138.
20. Dhingra V, Vishweshwar RK, Lakshmi NM. Current status of artemisinin and its derivatives as antimalarial drugs. Life Sci 2000;66:279-300.
21. Posner GH. Antimalarial peroxides in the qinghaosu (artemisinin) and yingzhaosu families. Exp Opin Ther Patents 1998;8:1487-1494.
22. Robert A, Dechy-Cabaret O, Cazelles J, Meunier B. From mechanistic studies on artemisinin derivatives to new modular antimalarial drugs. Acc Chem Res 2002;35:167-174.
23. Dong Y, Vennerstrom JL. Peroxidic antimalarials. Exp Opin Ther Patents 2001;11:1753-1760.
24. Dong Y. Synthesis and antimalarial activity of 1,2,4,5-tetraoxanes. Mini-Rev Med Chem 2002;2:113-123.
25. Borstnik K, Paik I-H, Shapiro TA, Posner GH. Antimalarial chemotherapeutic peroxides: Artemisinin, yingzhaosu A, and related compounds. Int J Parasitol 2002;32:1661-1667.
26. Jung M, Li X, Bustos DA, ElSohly HN, McChesney JD, Milhous WK. Synthesis and antimalarial activity of (+)-deoxoartemisinin. J Med Chem 1990;33:1516-1518.
27. Vennerstrom JL, Dong Y, Andersen SL, Ager AL, Jr., Fu H, Miller RE, Wesche DL, Kyle DE, Gerena L, Walters SM, Wood JK, Edwards G, Holme AD, McLean WG, Milhous WK. Synthesis and antimalarial activity of sixteen dispiro-1,2,4, 5-tetraoxanes: Alkyl-substituted 7,8,15,16-tetraoxadispiro[5.2.5.2]hexadecanes. J Med Chem 2000;43:2753-2758.
28. Bachi MD, Korshin EE, Hoos R, Szpilman AM, Ploypradith P, Xie S, Shapiro TA, Posner GH. A short synthesis and biological evaluation of potent and nontoxic antimalarial bridged bicyclic β-sulfonyl-endoperoxides. J Med Chem 2003;46:2516-2533.
29. Peters W. Chemotherapy and drug resistance in malaria, 2nd edn., Vol. 1. London: Academic Press; 1987. pp 97-174.
30. 2-bis(7-chloroquinolin-4-yl)cyclohexane-1,2- diamine: Comparison of two stereoisomers and detailed evaluation of the S,S enantiomer, Ro 47-7737. Antimicrob Agents Chemother 1997;41:677-686.
31. Department of Phytochemistry, Institute of Materia Medica, Chinese Academy of Medical Sciences. Summary of the research of Chinese traditional and herbal medicines. Acta Pharm Sinica 1979;14:746-768.
32. Xu XX, Zhu J, Huang DZ, Zhou WS. Total synthesis of (+)-Yingzhaosu A. Tetrahedron Lett 1991;32:5785-5788.
33. Jaquet C, Stohler HR, Chollet J, Peters W. Antimalarial activity of the bicyclic peroxide Ro 42-1611 (arteflene) in experimental models. Trop Med Parasitol 1994;45:266-271.
34. Hofheinz W, Burgin H, Gocke E, Jaquet C, Masciadri R, Schmid G, Stohler H, Urwyler H. Ro 42-1611 (arteflene), a new effective antimalarial: Chemical structure and biological activity. Trop Med Parasitol 1994;45:261-265.
35. Salako LA, Guiguemde R, Mittelholzer M-L, Haller L, Sorenson F, Stürchler D. Ro 42-1611 in the treatment of patients with mild malaria: A clinical trial in Nigeria and Burkina Faso. Trop Med Parasitol 1996;45:284-287.
36. Girometta MA, Jauch R, Ponelle C, Guenzi A, Wiegand-Chou RC. Animal pharmacokinetics and metabolism of the new antimalarial Ro 42-1611 (arteflene). Trop Med Parasitol 1994;45:272-277.
37. Korshin EE, Hoos R, Szpilman AM, Konstantinovski L, Posner GH, Bachi MD. An efficient synthesis of bridged-bicyclic peroxides structurally related to antimalarial yingzhaosu A based on radical cooxygenation of thiols and monoterpenes. Tetrahedron 2002;58:2449-2469.
38. Bachi MD, Korshin EE. Thiol-oxygen cooxidation of monoterpenes. Synthesis of endoperoxides structurally related to antimalarial yingzhaosu A. Synlett 1998;122-124.
39. Bachi MD, Korshin EE, Ploypradith P, Cumming JN, Xie S, Shapiro TA, Posner GH. Synthesis and in vitro antimalarial activity of sulfone endoperoxides. Bioorg Med Chem Lett 1998;8:903-908.
40. Kim HS, Begum K, Ogura N, Wataya Y, Tokuyasu T, Masuyama A, Nojima M, McCullough KJ. Antimalarial activity of yingzhaosu A analogues. J Med Chem 2002;45:4732-4736.
41. Vennerstrom JL, Acton N, Lin AJ, Klayman DL. Peroxides as oxidant antimalarials. Drug Des Deliv 1989;4:45-54.
42. Kepler JA, Philip A, Lee YW, Musallam HA, Carroll FI. Endoperoxides as potential antimalarial agents. J Med Chem 1987;30:1505-1509.
43. Kamata M, Ohta M, Komatsu K, Kim HS, Wataya Y. Synthesis, Fe(II)-induced degradation, and antimalarial activities of 1,5-diaryl-6,7-dioxabicyclo[3.2.2] nonanes: Direct evidence for nucleophilic O-1,2-aryl shifts. Tetrahedron Lett 2002;43:2063-2067.
44. Posner GH, Wang D, González L, Tao X, Cumming JN, Klinedinst D, Shapiro TA. Mechanism-based design of simple, symmetrical, easily prepared, potent antimalarial endoperoxides. Tetrahedron Lett 1996;37:815-818.
45. Posner GH, Gonzalez L, Cumming JN, Klinedinst D, Shapiro TA. Synthesis and antimalarial activity of heteroatom-containing bicyclic endoperoxides. Tetrahedron 1997;53:37-50.
46. Posner GH, Tao X, Cumming JN, Klinedinst D, Shapiro TA. Antimalarially potent, easily prepared, fluorinated endoperoxides. Tetrahedron Lett 1996;37:7225-7228.
47. Rücker G, Breitmaier E, Manns D, Maier W, Marek A, Heizmann B, Heiden K, Seggewies S. Antimalarial activity of 1,4-epidioxy-bisabola-2,12-diene derivatives. Arch Pharm Pharm Med Chem 1997;330:12-16.
48. Tani S, Fukamiya N, Kiyokawa H, Musallam HA, Pick RO, Lee KH. Antimalarial agents. 1. α-Santonin-derived cyclic peroxide as potential antimalarial agent. J Med Chem 1985;28:1743-1744.
49. O'Neill PM, Searle NL, Raynes KJ, Maggs JL, Ward SA, Storr RC, Park BK, Posner GH. A carbonyl oxide route to antimalarial yingzhaosu A analogs: Synthesis and antimalarial activity. Tetrahedron Lett 1998;39:6065-6068.
50. Tokuyasu T, Masuyama A, Nojima M, Kim HS, Wataya Y. Synthesis and anti-malarial activity of yingzhaosu A analogs from unsaturated hydroperoxy acetals. Tetrahedron Lett 2000;41:3145-3148.
51. Tokuyasu T, Masuyama A, Nojima M, McCullough KJ, Kim HS, Wataya Y. Yingzhaosu A analogues: Synthesis by the ozonolysis of unsaturated hydroperoxides, structural analysis, and determination of antimalarial activity. Tetrahedron 2001;57:5979-5989.
52. Posner GH, O'Dowd H, An antimalarially active cyclic peroxy ketal. Heterocycles 1998;47:643-646.
53. Posner GH, O'Dowd H, Ploypradith P, Cumming JN, Xie S, Shapiro TA. Antimalarial cyclic peroxy ketals. J Med Chem 1998;41:2164-2167.
54. Murakami N, Kawanishi M, Itagaki S, Horii T, Kobayashi M. New readily accessible peroxides with high antimalarial potency. Bioorg Med Chem Lett 2002;12:69-72.
55. Howarth J, Wilson D. 1,4-Dihydroxy-2,3-dioxatricyclo[8.4.0.0.4.9] tetradecane and derivatives with in vitro activity against Plasmodium falciparum, Trypanasoma b brucei, Trypanasoma cruzi, and Leishmaniasis infantum. Bioorg Med Chem Lett 2003;13:2013-2015.
56. Bunnelle WH, Isbell TA, Barnes CL, Qualls S. Cationic ring expansion of an ozonide to a 1,2,4-trioxane. J Am Chem Soc 1991;113:8168-8169.
57. Casteel DA, Peri SP, Gerena L. Synthesis and antimalarial evaluation of 2,3,5-trioxabicyclo[2.2.3]nonane, a model for the putative pharmacophore of artemisinin. Bioorg Med Chem Lett 1993;3:1707-1710.
58. Casteel DA, Jung KE, Gernea L, Milhous W. Synthesis and antimalarial evaluation of 2,3,5-trioxabicyclo[2.2.2]octanes, models for the putative pharmacophore of qinghaosu (artemisinin). Bioorg Med Chem Lett 1992;2:623-626.
59. Jefford CW, Velarde JA, Bernardinelli G, Bray DH, Warhurst DC, Milhous WK. Synthesis, structure, and antimalarial activity of tricyclic 1,2,4-trioxanes related to artemisinin. Helv Chim Acta 1993;76:2775-2788.
60. Posner GH, Oh CH, Milhous WK. Olefin oxidative cleavage and dioxetane formation using triethylsilyl hydrotrioxide: Applications to preparation of potent antimalarial 1,2,4-trioxanes. Tetrahedron Lett 1991;32:4235-4238.
61. Posner GH, Cumming JN, Woo SH, Ploypradith P, Xie S, Shapiro TA. Orally active antimalarial 3-substituted trioxanes: New synthetic methodology and biological evaluation. J Med Chem 1998;41:940-951.
62. Haraldson CA, Karle JM, Freeman SG, Duvadie RK, Avery MA. The synthesis of 8,8-disubstituted tricyclic analogs of artemisinin. Bioorg Med Chem Lett 1997;7:2357-2362.
63. Posner GH, O'Dowd H, Caferro T, Cumming JN, Ploypradith P, Xie S, Shapiro TA. Antimalarial sulfone trioxanes. Tetrahedron Lett 1998;39:2273-2276.
64. Avery Mitchell A, Mehrotra Sanjiv, Bonk Jason D, Vroman Jeffrey A, Goins D, Keith Miller Robert. Structure-activity relationships of the antimalarial agent artemisinin. 4. Effect of substitution at C-3. J Med Chem 1996;39:2900-2906.
65. Posner GH, Maxwell JP, O'Dowd H, Krasavin M, Xie S, Shapiro TA. Antimalarial sulfide, sulfone, and sulfonamide trioxanes. Bioorg Med Chem 2000;8:1361-1370.
66. Posner GH, Oh CH, Gerena L, Milhous WK. Extraordinarily potent antimalarial compounds: New, structurally simple, easily synthesized, tricyclic 1,2,4-trioxanes. J Med Chem 1992;35:2459-2467.
67. Posner GH, McGarvey DJ, Oh CH, Kumar N, Meshnick SR, Asawamahasadka W. Structure-activity relationships of lactone ring-opened analogs of the antimalarial 1,2,4-trioxane artemisinin. J Med Chem 1995;38:607-612.
68. Cumming JN, Wang D, Park SB, Shapiro TA, Posner GH. Design, synthesis, derivatization, and structure-activity relationships of simplified, tricyclic, 1,2,4-trioxane alcohol analogs of the antimalarial artemisinin. J Med Chem 1998;41:952-964.
69. Posner GH, Oh CH, Webster HK, Ager AL, Rossan RN. New, antimalarial, tricyclic 1,2,4-trioxanes: Evaluations in mice and monkeys. Am J Trop Med Hyg 1994;50:522-526.
70. Cazelles J, Robert A, Meunier B. Alkylating capacity and reaction products of antimalarial trioxanes after activation by a heme model. J Org Chem 2002;67:609-619.
71. Olliaro PL, Haynes RK, Meunier B, Yuthavong Y. Possible modes of action of the artemisinin-type compounds. Trends Parasitol 2001;17:122-126.
72. Posner GH, Jeon HB, Parker MH, Krasavin M, Paik IH, Shapiro TA. Antimalarial simplified 3-aryltrioxanes: Synthesis and preclinical efficacy/toxicity testing in rodents. J Med Chem 2001;44:3054-3058.
73. Posner GH, Jeon HB, Ploypradith P, Paik IH, Borstnik K, Xie S, Shapiro TA. Orally active, water-soluble antimalarial 3-aryltrioxanes: Short synthesis and preclinical efficacy testing in rodents. J Med Chem 2002;45:3824-3828.
74. Jefford CW, Misra D, Rossier JC, Kamalaprija P, Burger U, Mareda J, Bernardinelli G, Peters W, Robinson BL, Milhous WK, Zhang F, Gosser DK, Jr., Meshnick SR. Cyclopenteno-1,2,4-trioxanes as effective antimalarial surrogates of artemisinin. In: Testa B, Kyburz E, Fuhrer W, Gifer R, editors. Perspectives in medicinal chemistry. Basel: VCH; 1993. pp 459-472.
75. Jefford CW, Boukouvalas J, Kohmoto S. Reactions of cyclic peroxides with aldehydes and ketones catalyzed by trimethylsilyl trifluoromethanesulfonate. An efficient synthesis of 1,2,4-trioxanes. J Chem Soc Chem Commun 1984;523-524.
76. Peters W, Robinson BL, Rossier JC, Misra D, Jefford CW, Rossier JC. The chemotherapy of rodent malaria. XLIX. The activities of some synthetic 1,2,4-trioxanes against chloroquine-sensitive and chloroquine-resistant parasites. Part 2: Structure-activity studies on cis-fused cyclopenteno-1,2,4- trioxanes (fenozans) against drug-sensitive and drug-resistant lines of Plasmodium berghei and P. yoelii ssp. NS in vivo. Ann Trop Med Parasitol 1993;87:9-16.
77. Jefford CW, Rossier JC, Milhous WK. The structure and anfimalarial activity of some 1,2,4-trioxanes, 1,2,4,5-tetroxanes, and bicyclic endoperoxides. Implications for the mode of action. Heterocycles 2000;52:1345-1352.
78. Jefford CW, Kohmoto S, Jaggi D, Timari G, Rossier J-C, Rudaz M, Barbuzzi O, Gerard D, Burger U. Synthesis, structure, and antimalarial activity of some enantiomerically pure, cis-fused cyclopenteno-1,2,4-trioxanes. Helv Chim Acta 1995;78:647-662.
79. Jefford CW, Jaggi D, Kohmoto S, Timari G, Bernardinelli G, Canfield CJ, Milhous WK. The structure and antimalarial activity of some cis-fused bicyclic 1,2,4-trioxane derivatives. Heterocycles 1998;49:375-384.
80. Peters W, Robinson BL, Rossier JC, Jefford CW. The chemotherapy of rodent malaria. XLVIII. The activities of some synthetic 1,2,4-trioxanes against chloroquine-sensitive and chloroquine-resistant parasites. Part 1: Studies leading to the development of novel cis-fused cyclopenteno derivatives. Ann Trop Med Parasitol 1993;87:1-7.
81. Peters W, Robinson BL, Tovey G, Rossier JC, Jefford CW. The chemotherapy of rodent malaria. L. The activities of some synthetic 1,2,4-trioxanes against chloroquine-sensitive and chloroquine-resistant parasites. Part 3: Observations on 'Fenozan-50F', a difluorinated 3,3′-spirocyclopentane 1,2,4-trioxane. Ann Trop Med Parasitol 1993;87:111-123.
82. Fleck SL, Robinson BL, Peters W, Thevin F, Boulard Y, Glenat C, Caillard V, Landau I. The chemotherapy of rodent malaria. LIII. 'Fenozan B07' (Fenozan-50F), a difluorinated 3,3′-spirocyclopentane 1,2,4-trioxane: Comparison with some compounds of the artemisinin series. Ann Trop Med Parasitol 1997;91:25-32.
83. Fleck SL, Robinson BL, Peters W. The chemotherapy of rodent malaria. LIV. Combinations of 'Fenozan B07' (Fenozan-50F), a difluorinated 3,3′-spiorocyclopentane 1,2,4-trioxane, with other drugs against drug-sensitive and drug-resistant parasites. Ann Trop Med Parasitol 1997;91:33-39.
84. Griesbeck AG, El-Idreesy TT, Fiege M, Brun R. Synthesis of antimalarial 1,2,4-trioxanes via photooxygenation of a chiral allylic alcohol. Org Lett 2002;4:4193-4195.
85. O'Neill PM, Pugh M, Davies J, Ward SA, Park BK. Regioselective Mukaiyama hydroperoxysilylation of 2-alkyl- or 2-aryl-prop-2-en-1-ols: Application to a new synthesis of 1,2,4-trioxanes. Tetrahedron Lett 2001;42:4569-4571.
86. Singh C, Gupta N, Puri SK. Photo-oxygenation of geraniol: Synthesis of a novel series of hydroxy-functionalized anti-malarial 1,2,4-trioxanes. Bioorg Med Chem Lett 2002;12:1913-1916.
87. Singh C. Preparation of β-hydroxyhydroperoxides by photooxygenation of allylic alcohols and their elaboration into 1,2,4-trioxanes. Tetrahedron Lett 1990;31:6901-6902.
88. Singh C, Misra D, Saxena G, Chandra S. Synthesis of in vivo potent antimalarial 1,2,4-trioxanes. Bioorg Med Chem Lett 1992;2:497-500.
89. Singh C, Misra D, Saxena G, Chandra S. In vivo potent antimalarial 1,2,4-trioxanes: Synthesis and activity of 8-(α-arylvinyl)-6,7,10- trioxaspiro[4,5]decanes and 3-(α-arylvinyl)-1,2,5-trioxaspiro[5,5] undecanes against Plasmodium berghei in mice. Bioorg Med Chem Lett 1995;5:1913-1916.
90. Kepler JA, Philip A, Lee YW, Morey MC, Carroll FI. 1,2,4-Trioxanes as potential antimalarial agents. J Med Chem 1988;31:713-716.
91. Jefford CW, McGoran EC, Boukouvalas J, Richardson G, Robinson BL, Peters W. Synthesis of new 1,2,4-trioxanes and their antimalarial activity. Helv Chim Acta 1988;71:1805-1812.
92. Rong YJ, Wu YL. Synthesis of steroidal 1,2,4-trioxane as potential antimalarial agent. J Chem Soc [Perkin 1] 1993;2149-2150.
93. Vennerstrom JL, Fu HN, Ellis WY, Ager AL, Jr., Wood JK, Andersen SL, Gerena L, Milhous WK. Dispiro-1,2,4,5-tetraoxanes: A new class of antimalarial peroxides. J Med Chem 1992;35:3023-3027.
94. Vennerstrom JL, Ager AL, Jr., Andersen SL, Grace JM, Wongpanich V, Angerhofer CK, Hu JK, Wesche DL. Assessment of the antimalarial potential of tetraoxane WR 148999. Am J Trop Med Hyg 2001;62:573-578.
95. Dong Y, Vennerstrom JL. Dispiro-1,2,4,5-tetraoxanes via ozonolysis of cycloalkanone O-methyl oximes: A comparison with the peroxidation of cycloalkanones in acetonitrile sulfuric acid media. J Org Chem 1998;63:8582-8585.
96. Dong Y, Matile H, Chollet J, Kaminsky R, Wood JK, Vennerstrom JL. Synthesis and antimalarial activity of 11 dispiro-1,2,4,5-tetraoxane analogues of WR 148999:7,8,15,16-tetraoxadispiro[5.2.5.2]hexadecanes substituted at the I and 10 positions with unsaturated and polar functional groups. J Med Chem 1999;42:1477-1480.
97. Kim HS, Shibata Y, Wataya Y, Tsuchiya K, Masuyama A, Nojima M. Synthesis and antimalarial activity of cyclic peroxides, 1,2,4,5,7-pentoxocanes and 1,2,4,5-tetroxanes. J Med Chem 1999;42:2604-2609.
98. Kim HS, Tsuchiya K, Shibata Y, Wataya Y, Ushigoe Y, Masuyama A, Nojima M, McCullough KJ. Synthetic methods for unsymmetrically-substituted 1,2,4,5-tetroxanes and of 1,2,4,5,7-pentoxocanes. J Chem Soc [Perkin 1] 1999;1867-1870.
99. Solaja BA, Terzic N, Pocsfalvi G, Gerena L, Tinant B, Opsenica D, Milhous WK. Mixed steroidal 1,2,4,5-tetraoxanes: Antimalarial and antimycobacterial activity. J Med Chem 2002;45:3331-3336.
100. Opsenica D, Pocsfalvi G, Juranic Z, Tinant B, Declercq JP, Kyle PE, Milhous WK, Solaja BA. Cholic acid derivatives as 1,2,4,5-tetraoxane carriers: Structure and antimalarial and antiproliferative activity. J Med Chem 2000;43:3274-3282.
101. Todorovic NM, Stefanovic M, Tinant B, Declercq JP, Makler MT, Solaja BA. Steroidal geminal dihydroperoxides and 1,2,4,5-tetraoxanes: Structure determination and their antimalarial activity. Steroids 1996;61:688-696.
102. Opsenica D, Angelovski G, Pocsfalvi G, Juranic Z, Zizak Z, Kyle D, Milhous WK, Solaja BA. Antimalarial and antiproliferative evaluation of bis-steroidal tetraoxanes. Bioorg Med Chem 2003;11:2761-2768.
103. Opsenica D, Pocsfalvi G, Milhous WK, Solaja BA. Antimalarial peroxides: The first intramolecular 1,2,4,5-tetraoxane. J Serb Chem Soc 2002;67:465-471.
104. Tsuchiya K, Hamada Y, Masuyama A, Nojima M, McCullough KJ, Kim HS, Shibata Y, Wataya Y. Synthesis, crystal structure, and anti-malarial activity of novel spiro-1,2,4,5-tetraoxacycloalkanes. Tetrahedron Lett 1999;40:4077-4080.
105. Kim HS, Nagai Y, Ono K, Begum K, Wataya Y, Hamada Y, Tsuchiya K, Masuyama A, Nojima M, McCullough KJ. Synthesis and antimalarial activity of novel medium-sized 1,2,4,5-tetraoxacycloalkanes. J Med Chem 2001;44:2357-2361.
106. Nonami Y, Tokuyasu T, Masuyama A, Nojima M, McCullough KJ, Kim HS, Wataya Y. Synthesis, crystal structure, and antimalarial activity of functionalized spiro-1,2,4,5-tetraoxacycloalkanes from unsaturated hydroperoxy peracetals. Tetrahedron Lett 2000;41:4681-4684.
107. McCullough KJ, Nonami Y, Masuyama A, Nojima M, Kim HS, Wataya Y. Synthesis, crystal structure, and antimalarial activity of novel 1,2,5,6-tetraoxacycloalkanes from 2,3-dihydroperoxy-2-phenylnorbornane. Tetrahedron Lett 1999;40:9151-9155.
108. Kim HS, Begum K, Ogura N, Wataya Y, Nonami Y, Ito T, Masuyama A, Nojima M, McCullough KJ. Antimalarial activity of novel 1,2,5,6-tetraoxacycloalkanes and 1,2,5-trioxacycloalkanes. J Med Chem 2003;46:1957-1961.
109. Vennerstrom JL. Amine peroxides as potential antimalarials. J Med Chem 1989;32:64-67.
110. Sundar N, Jacob VT, Bhat SV, Valecha N, Biswas S. Antimalarial t-butylperoxyamines. Bioorg Med Chem Lett 2001;11:2269-2272.
111. Dechy-Cabaret O, Benoit-Vical F, Robert A, Meunier B. Preparation and antimalarial activities of "trioxaquines", new modular molecules with a trioxane skeleton linked to a 4-aminoquinoline. Chem BioChem 2000;1:281-283.
112. Dechy-Cabaret O, Benoit-Vical F, Robert A, Meunier B. Preparation and antimalarial activities of "trioxaquines", new modular molecules with a trioxane skeleton linked to a 4-aminoquinoline. Actualite Chim 2001;9-11.
113. Basco LK, Dechy-Cabaret O, Ndounga M, Meche FS, Robert A, Meunier B. In vitro activities of DU-1102, a new trioxaquine derivative, against Plasmodium falciparum isolates. Antimicrob Agents Chemother 2001;45:1886-1888.
114. Pitt MJ, Easton CJ, Robertson TA, Kumaratilake LM, Ferrante A, Poulos A, Rathjen DA. Synthesis of hydroperoxide and perketal derivatives of polyunsaturated fatty acids as potential antimalarial agents. Tetrahedron Lett 1998;39:4401-4404.
115. Cointeaux L, Berrien JF, Peyrou V, Provot O, Ciceron L, Danis M, Robert A, Meunier B, Mayrargue J. Synthesis and antimalarial activity of 2-methoxyprop-2-yl peroxides derivatives. Bioorg Med Chem Lett 2003;13:75-77.
116. Hamada Y, Tokuhara H, Masuyama A, Nojima M, Kim HS, Ono K, Ogura N, Wataya Y. Synthesis and notable antimalarial activity of acyclic peroxides, 1-(alkyldioxy)-1-(methyldioxy)cyclododecanes. J Med Chem 2002;45:1374-1378.
117. Helesbeux JJ, Peyronnet D, Labaied M, Grellier P, Frappier F, Seraphin D, Richomme P, Duval O. Synthesis and antimalarial activity of some new 1,2-dioxolane derivatives. J Enzyme Inhib Med Chem 2002;17:431-437.
118. de Almeida Barbosa LC, Cutler D, Mann J, Crabbe MJ, Kirby GC, Warhurst DC. The design, synthesis and biological evaluation of stable ozonides with antimalarial activity. J Chem Soc [Perkin 1] 1996;1101-1105.
119. de Almeida Barbosa LC, Cutler D, Mann J, Kirby GC, Warhurst DC. Synthesis of some stable ozonides with anti-malarial activity. J Chem Soc [Perkin 1] 1992;3251-3252.
120. Lipinski CA, Lombardo F, Dominy BW, Feeney PJ. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv Drug Deliv Rev 1997;23:3-26.
121. Veber DF, Johnson SR, Cheng H-Y, Smith BR, Ward KW, Kopple KD. Molecular properties that influence the oral bioavailability of drug candidates. J Med Chem 2002;45:2615-2623.
122. Wenlock MC, Austin RP, Barton P, Davis AM, Leeson PD. A comparison of physicochemical property profiles of development and marketed oral drugs. J Med Chem 2003;46:1250-1256.
123. Fujisaka T, Miura M, Nojima M, Kusabayashi S. Synthesis and reactions of 1,2,4-trioxanes. J Chem Soc [Perkin 1] 1989;1031-1039.
124. van de Waterbeemd H, Smith DA, Beaumont K, Walker DK. Property-based design: Optimization of drug absorption and pharmacokinetics. J Med Chem 2001;44:1313-1333.
125. Thompson TN. Optimization of metabolic stability as a goal of modern drug design. Med Res Rev 2001;21:412-449.
126. Zouhiri F, Desmaële D, d'Angelo J, Mahuteau J, Riche C, Gay F, Cicéron L. Artemisinin tricyclic analogs bearing a methyl group at C-5a: Preparation and antimalarial activity. Eur J Org Chem 1998;2897-2906.
127. McCullough KJ, Wood JK, Bhattacharjee AK, Dong Y, Kyle DE, Milhous WK, Vennerstrom JL. Methyl-substituted dispiro-1,2,4,5-tetraoxanes: Correlations of structural studies with antimalarial activity. J Med Chem 2000;43:1246-1249.
128. Jefford CW, Burger U, Millasson-Schmidt P, Bemardinelli G, Robinson BL, Peters W. Epiartemisinin, a remarkably poor antimalarial: Implications for the mode of action. Helv Chim Acta 2000;83:1239-1246.
129. Wesche DL, DeCoster MA, Tortella FC, Brewer TG. Neurotoxicty of artemisinin analogs in vitro. Antimicrob Agents Chemother 1994;38:1813-1819.
130. Park BK, O'Neill PM, Maggs JL, Pirmohamed M. Safety assessment of peroxide antimalarials: Clinical and chemical perspectives. Br J Clin Pharmacol 1998;46:521-529.